Tokyo, April 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061219) titled 'A Registry Study of Early-Stage and Locally Advanced KRAS-Mutant Non-Small Cell Lung Cancer' on April 10.
Study Type:
Observational
Primary Sponsor:
Institute - Wakayama Medical University
Condition:
Condition - Non-small cell lung cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - The objective of this study is to evaluate the prognosis of patients with early-stage or locally advanced non-small cell lung cancer harboring KRAS G12C mutations who have received standard treatment.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=...